91 results on '"Riddell, Stanley R"'
Search Results
2. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks
3. Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
4. Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies
5. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
6. Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function
7. NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness
8. A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
9. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
10. Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
11. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
12. Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma
13. Chimeric antigen receptor–modified T cells: CD19 and the road beyond
14. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation
15. Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
16. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
17. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
18. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL
19. TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
20. Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells
21. CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma Using a Fully Human CD19-Targeted Single Chain Variable Fragment: Results of a First-in-Human Phase I/II Study
22. Efficacy and Safety of CAR T-Cell Therapy Using a Fully Human CD19-Targeted Binder in Adults with Relapsed/Refractory B-ALL
23. Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
24. Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo
25. Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond
26. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
27. Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
28. Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation
29. Post-CAR-T Checkpoint Inhibition Can Result in Durable Responses in a Minority of Patients with Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL): Results of a Phase 2 Study of Nivolumab after CAR-T Failure
30. IL15 (N-803) and IL21 (oHSV-21) Significantly Enhance ROR1 CAR NK Cells Against Pediatric Neuroblastoma
31. Safety and Efficacy of Fully-Human-Binder-Bearing CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma after Failure of Murine-Binder-Bearing CD19 CAR T-Cell Therapy
32. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
33. National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee
34. The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
35. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
36. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
37. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit
38. Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
39. Safety and immunologic effects of IL-15 administration in nonhuman primates
40. HapMap scanning of novel human minor histocompatibility antigens
41. Generation of HIV-1–specific CD8+ cell responses following allogeneic hematopoietic cell transplantation
42. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
43. 124 - Phase I Trial of CAR T-Cell Therapy Using a Fully Human CD19-Targeted Binder for Adults with Relapsed/Refractory B-ALL
44. 15 - Fully Human CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Results of a First-in-Human Phase I/II Study
45. Adoptive Transfer of Allogeneic Antigen-Specific T Cells
46. High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy
47. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation
48. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection
49. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
50. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.